Peter Attia· MD
now 23 people died in the placebo arms collectively of the multipurviewer and paxlavid trials zero died of covet in the treatment arms
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
now 23 people died in the placebo arms collectively of the multipurviewer and paxlavid trials zero died of covet in the treatment arms
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the therapeutics we have today have cut cova deaths to zero in the clinical trials and once they get distributed remember they were just fda approved once they get distributed and out there no one should be dying of covet right now with rare exceptions with all the you know state of the art care with the randomized controlled trial data behind it and pax levitt and money preview no one has died from covid in those clinical trials period